The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Axfood AB
STO:AXFO
|
SE |
|
Krasnoyarskenergosbyt PAO
MOEX:KRSB
|
RU |
|
A
|
ASN Broker PCL
SET:ASN
|
TH |
|
Certive Solutions Inc
OTC:CTVEF
|
CA |
|
F
|
First Tractor Co Ltd
SSE:601038
|
CN |
|
R
|
Revive Therapeutics Ltd
CNSX:RVV
|
CA |
|
A
|
ArriVent BioPharma Inc
NASDAQ:AVBP
|
US |
|
Red Cat Holdings Inc
F:BQ73
|
PR |
|
B
|
Berdikari Pondasi Perkasa Tbk PT
IDX:BDKR
|
ID |
|
Fujifilm Holdings Corp
F:FJIA
|
JP |
|
M
|
Malakoff Corp Bhd
KLSE:MALAKOF
|
MY |
|
D
|
Draganfly Inc
CNSX:DPRO
|
CA |
|
U
|
Unimech Group Bhd
KLSE:UNIMECH
|
MY |
|
Orsted A/S
CSE:ORSTED
|
DK |
|
H
|
H & R Block Inc
SWB:HRB
|
US |
|
Ganga Papers India Ltd
BSE:531813
|
IN |
|
B
|
BlueVenture Group PCL
SET:BVG
|
TH |
|
I
|
Innoprise Plantations Bhd
KLSE:INNO
|
MY |
|
S
|
Swatch Group AG
DUS:UHR
|
CH |
|
E
|
Empire Diversified Energy Inc
OTC:MPIR
|
US |
|
Viohalco SA
F:VHC
|
BE |
Axfood AB (AXFO)’s 12-month stock price forecast through October 2027 has a consensus target of kr280.5, implying 4% upside. The forecast is based on price targets from 9 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
AXFO is 280.5 SEK with a low forecast of 217.15 SEK and a high forecast of 315 SEK.
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 12%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 7%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 9%.
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 5 years is 11%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more